Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375530 · ClinicalTrials.gov registry record
Screening Volunteers for Clinical Trials
A clinical trial of Screening, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 4
- Study locations
NCT01375530: Recruiting study of Screening, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01375530 is a study of Screening that is actively recruiting participants, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 4,000 participants, above the 1,132-participant average among 3 other Screening trials with a reported enrollment target (253% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01375530, a study of Screening, is actively recruiting participants, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Background: \- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work. Objectives: \- To screen healthy volunteers for clinical trials at the NIAID VRC. Eligibility: \- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies. Design: * Screening for healthy volunteers to participate in clinical trials is an ongoing process. * Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed. * Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status. * Volunteers will not receive any investigational product in this screening protocol.
Primary Outcome
Duration of subject participation is variable, and may last from a few weeks to several months for each subject.
Conditions Studied
Study Locations (4)
Maryland
- Univ of MD School of Medicine Center for Vaccine Development & Global Health - Baltimore
- National Institutes of Health Clinical Center - Bethesda
Georgia
- Emory University - Atlanta
Pennsylvania
- University of Pennsylvania-UPenn - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2011-08-16 |
What NCT01375530 shows while recruiting
NCT01375530 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,132-participant average among 3 other Screening trials with a reported enrollment target (253% higher).
The record links to 1 condition, with Screening appearing as the primary indexed condition, and to 0 interventions.
NCT01375530 reports a single indexed study location in Maryland, Georgia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01375530 about?
NCT01375530 is a clinical study titled "Screening Volunteers for Clinical Trials". Background: \- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical tria...
What is the current status of trial NCT01375530?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2011-08-16.
What conditions does trial NCT01375530 study?
This clinical trial studies the following conditions: Screening.
Who is sponsoring clinical trial NCT01375530?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01375530 being conducted?
This trial has 4 study locations across Georgia, Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
RECRUITING · NA
-
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
RECRUITING · NA
-
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI